Inoky-Glucotest (Glucose)

Glucose is absorbed through the intestinal wall into the bloodstream, where it is transported into cells via GLUT transporters. Inside cells it enters glycolysis and subsequent metabolic pathways, producing ATP that fuels cellular activities and maintains normal physiological functions.

The appropriate dose of Inoky-Glucotest is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, weight, and blood‑glucose status. Patients should follow the specific instructions provided by their prescriber.

Safety data for Inoky-Glucotest in pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit profile for each patient and consider alternative options if necessary. Pregnant or nursing individuals should consult their physician before use.

To place an order, submit an enquiry on the Inoky-Glucotest product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inoky-Glucotest is an OTC oral glucose formulation meeting EU quality standards. Compared with generic glucose powders or tablets, it offers a standardized dosage and excipient profile, ensuring consistent bioavailability and ease of administration in clinical and retail environments.

Store Inoky-Glucotest at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency and stability.

Inoky-Glucotest is taken orally. The product may be dissolved in water or another suitable liquid, or swallowed directly, depending on the formulation provided. Administration should follow the prescriber’s instructions regarding timing and amount.

The most serious risks include severe hyperglycemia, which can lead to complications such as diabetic ketoacidosis, and allergic reactions that may present as rash, swelling, or difficulty breathing. Immediate medical attention is required if these symptoms occur.

Individuals with known hypersensitivity to glucose or any excipients in the formulation should avoid use. Patients with uncontrolled diabetes, severe renal or hepatic impairment, or those on specific glucose‑lowering regimens should consult a healthcare professional before taking the product.